Cardio Diagnostics Holdings (CDIO) EBIAT (2021 - 2025)
Historic EBIAT for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.
- Cardio Diagnostics Holdings' EBIAT fell 2137.74% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 2061.01%. This contributed to the annual value of -$8.4 million for FY2024, which is 7.9% down from last year.
- Cardio Diagnostics Holdings' EBIAT amounted to -$1.7 million in Q3 2025, which was down 2137.74% from -$1.7 million recorded in Q2 2025.
- In the past 5 years, Cardio Diagnostics Holdings' EBIAT registered a high of -$397.0 during Q2 2021, and its lowest value of -$4.2 million during Q1 2024.
- In the last 5 years, Cardio Diagnostics Holdings' EBIAT had a median value of -$1.4 million in 2023 and averaged -$1.5 million.
- As far as peak fluctuations go, Cardio Diagnostics Holdings' EBIAT plummeted by 21199017.63% in 2022, and later soared by 6798.35% in 2024.
- Quarter analysis of 5 years shows Cardio Diagnostics Holdings' EBIAT stood at -$144837.0 in 2021, then tumbled by 1541.89% to -$2.4 million in 2022, then skyrocketed by 41.59% to -$1.4 million in 2023, then fell by 9.39% to -$1.5 million in 2024, then decreased by 12.85% to -$1.7 million in 2025.
- Its EBIAT stands at -$1.7 million for Q3 2025, versus -$1.7 million for Q2 2025 and -$1.6 million for Q1 2025.